Lenalidomide and Dexamethasone combination useful for treating multiple myeloma patientsMultiple myeloma can be effectively treated by using a combination of lenalidomide and dexamethasone, according to a study that involved 353 patients with myeloma and conducted at 44 centers in the United States and Canada.

It was revealed during the study that pairing a new thalidomide derivative with a steroid can slow down the progression of multiple myeloma besides prolonging the lives of patients who have relapsed from earlier treatments.

Lead author Donna Weber, M.D., associate professor in the Department of Lymphoma and Myeloma at The University of Texas M. D. Anderson Cancer Center, said that the combination seems to be effective as the disease may become immune to one therapy.